Immunofluorometric assay for the metastasis-related protein S100A4: Release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum

被引:37
作者
Flatmark, K [1 ]
Maelandsmo, GM
Mikalsen, SO
Nustad, K
Varaas, T
Rasmussen, H
Meling, GI
Fodstad, O
Paus, E
机构
[1] Norwegian Radium Hosp, Dept Tumor Biol, NO-0310 Oslo, Norway
[2] Norwegian Radium Hosp, Inst Canc Res, NO-0310 Oslo, Norway
[3] Norwegian Radium Hosp, Dept Environm & Occupat Canc, NO-0310 Oslo, Norway
[4] Norwegian Radium Hosp, Cent Lab, NO-0310 Oslo, Norway
[5] Akershus Univ Hosp, Dept Surg, Nordbyhagen, Norway
关键词
S100A4; colorectal cancer; immunofluorometric assay; monoclonal antibodies;
D O I
10.1159/000077721
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The metastasis-related protein S100A4 is released from tumor cells, and since it is highly expressed in colorectal cancer (CRC), it could be a potential tumor marker in plasma or serum. Monoclonal antibodies (MAbs) were raised against human recombinant S100A4 and shown to detect native and recombinant antigen with high sensitivity and specificity. Using two MAbs, an immunofluorometric assay (IFMA) was established to detect S100A4 in clinical samples with high sensitivity and precision. S100A4 in plasma and serum from patients with CRC was highly influenced by sample hemolysis. Both red blood cells and mononuclear cells were found to contain S100A4, possibly contributing to the measured levels in serum and plasma. Since even very low-level hemolysis influenced the results, a potential contribution from an S100A4-expressing tumor could not be discerned, indicating that S100A4 is not suitable as a plasma or serum tumor marker for CRC. The antibodies and the IFMA may still be useful for research purposes. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 42 条
  • [1] The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor
    Ambartsumian, N
    Klingelhöfer, J
    Grigorian, M
    Christensen, C
    Kriajevska, M
    Tulchinsky, E
    Georgiev, G
    Berezin, V
    Bock, E
    Rygaard, J
    Cao, RH
    Cao, YH
    Lukanidin, E
    [J]. ONCOGENE, 2001, 20 (34) : 4685 - 4695
  • [2] Ambartsumian NS, 1996, ONCOGENE, V13, P1621
  • [3] BAYER EA, 1990, METHOD ENZYMOL, V184, P138
  • [4] Beaudeux JL, 2000, CLIN CHEM, V46, P989
  • [5] Bjerner J, 2002, CLIN CHEM, V48, P613
  • [6] DAVIES BR, 1993, ONCOGENE, V8, P999
  • [7] Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer
    Davies, BR
    O'Donnell, M
    Durkan, GC
    Rudland, PS
    Barraclough, R
    Neal, DE
    Mellon, JK
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 292 - 299
  • [8] Davies MPA, 1996, ONCOGENE, V13, P1631
  • [9] Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
    Donato, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1450 (03): : 191 - 231
  • [10] Extracellular role of S100A4 calcium-binding protein in the periodontal ligament
    Duarte, WR
    Iimura, T
    Takenaga, K
    Ohya, K
    Ishikawa, I
    Kasugai, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) : 416 - 420